Assertio

Viatris (NASDAQ: VTRS) Stock Quote Follow

Last Trade: US$9.33 0.13 1.41
Volume: 3,881,655
5-Day Change: -1.79%
YTD Change: -16.17%
Market Cap: US$11.290B

Latest News From Viatris

Smith, a seasoned senior healthcare executive, will lead the company's previously announced Phase 2 strategy and execution Board of Directors thanks Michael Goettler , who will support a smooth transition prior to his departure PITTSBURGH , Feb. 27, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as it prepares to enter Phase 2 of its previously announced strategic plan in... Read More
Company Meets its 2022 Adjusted Guidance After Incorporating the Fourth Quarter Impact of the Biosimilars Transaction and Acquired IPR&D 2023 Guidance Midpoint Reflects Revenue Growth Over 2022, Excluding Full-Year Impact of Biosimilars Reaffirms 2024 Phase 2 Outlook from November 7 Strategic Update Company Increases Return of Capital to Shareholders by Completing $250 Million in Share Repurchases Board of Directors Approves... Read More
PITTSBURGH , Feb. 15, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to report its fourth quarter and full year 2022 financial results on Monday, February 27 before the open of the U.S. financial markets. Chief Executive Officer Michael Goettler , President Rajiv Malik , and Chief Financial Officer Sanjeev Narula also will host a webcast at 8:30 a.m. ET on February 27 to discuss the results. Investors and the general... Read More
Division Combines Oyster Point Pharma's Eye Care Expertise with Famy Life Science's Phase III-ready Pipeline and Lays Foundation for Viatris to Become a Global Eye Care Leader Acquisitions Have the Potential to Add at Least $1 Billion in Sales by 2028 Transactions Showcase the Power of Viatris' Global Healthcare Gateway® PITTSBURGH , Jan. 3, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today... Read More
Directors Neil Dimick and Ian Read Retire PITTSBURGH , Dec. 29, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Scott A. Smith and Elisha W. Finney have been appointed as Viatris' newest members of its board of directors. Smith and Finney fill the vacancies created by the retirement of Neil Dimick and Ian Reid . Scott Smith is a deeply experienced global biotechnology and... Read More
PITTSBURGH , Dec. 23, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11 , 2023. Representing Viatris will be Chief Executive Officer Michael Goettler , President Rajiv Malik , Chief Financial Officer Sanjeev Narula and joined by Jeff Nau , CEO of Oyster... Read More
The contribution includes donations to four organizations: Direct Relief, World Central Kitchen, WaterAid and World Food Program USA PITTSBURGH , Dec. 14, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced it is donating a total of $1 million to aid in supporting access to healthcare, food security and water stewardship in communities around the world, through four organizations:... Read More
PITTSBURGH , Dec. 14, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that its near-term science-based emissions reduction targets have been approved by the Science Based Targets initiative (SBTi). SBTi is a global body enabling businesses to set ambitious emissions reduction targets in line with the latest climate science. Viatris President Rajiv Malik said, "This approval from... Read More

COPYRIGHT ©2023 HEALTH STOCKS HUB